O
Ontera Bio
Ontera.bio - Revolutionizing Molecular Diagnostics With Silicon Nanopore Technology | Ontera
About Ontera Bio
Ontera.bio operates in the biotechnology sector, specializing in advanced molecular diagnostics. The company leverages cutting-edge nanotechnology and artificial intelligence to provide precision healthcare solutions. Ontera.bio serves a diverse range of clients, including healthcare providers, research institutions, and pharmaceutical companies. The company's business model revolves around the development and commercialization of diagnostic tools that offer rapid, accurate, and cost-effective results. Revenue is generated through the sale of diagnostic devices, subscription-based access to their AI-driven analytics platform, and partnerships with pharmaceutical companies for drug development and personalized medicine.
Source: Dealroom company dataAt a glance
- Founded
- 2011
- Headquarters
- Santa Cruz, United States
- Sector
- Health
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ontera Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ontera Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.